US$ 25.38
l-carnitine biotech használata L BioTech USA L-Carnitine + Chrome
Description
This paper presents a seminal phase III trial of the antisense oligonucleotide nusinersen in infants with SMA-I

In research published in the journal Dementia and Neurocognitive Disorders, older patients (age 55 to 80 years), with a confirmed diagnosis of dementia or memory deficit due to cerebrovascular disease, received treatment with ALC 1500 mg for 28 days


Martinez SE, Vaglenova J, Sabria J, Martinez MC, Farres J, et al

L.et al (2017)
